FDA
-
-
-
-
-
-
-
EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis
-
-
-
-
-
-
-
EDAP (EDAP) Announces FDA Breakthrough Device Designation for Focal OneĀ® in the Treatment of Deep Infiltrating Rectal Endometriosis
-
-
-
-
-
-
-
EDAP Announces Presentation at the HC Wainwright Virtual 22nd Annual Global Investment Conference
-
-
-
-
-
-
-
EDAP Announces Approval for Phase II Study Evaluating High Intensity Focused Ultrasound (HIFU) for Deep Invasive EndometriosisĀ
-
-
-
-
-
-
-
EDAP Announces Recent Focal One Sales Successes
-
-
-
-
-
-
-
EDAP Reports First Quarter 2020 Results and Provides Operational Update
-
-
-
-
-
-
-
EDAP Reports Record Full Year 2019 Results and Provides Operational Update
-
322,090 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

